Sofosbuvir-Based Therapies for Patients With Hepatitis C Virus Infection: Real-World Experience in China

Canadian Journal of Gastroenterology and Hepatology- Egypt

doi 10.1155/2018/3908767

Full Text

Abstract

Available in

Date

Authors

Publisher

Hindawi Limited

Related search

Generic Sofosbuvir-Based Interferon-Free Direct Acting Antiviral Agents for Patients With Chronic Hepatitis C Virus Infection: A Real-World Multicenter Observational Study

Scientific Reports
Multidisciplinary
2018English

Daclatasvir Plus Sofosbuvir With or Without Ribavirin in Patients With Chronic Hepatitis C Genotype 3a in Pakistani Population - A Real World Experience

Pakistan Journal of Medical Sciences
Medicine
2019English

Sofosbuvir/Velpatasvir for Chronic Hepatitis C Infection in Patients With Transfusion-Dependent Thalassemia

American Journal of Hematology
Hematology
2018English

Secondary Occult Hepatitis C Virus Infection (HCV) in Chronic HCV Patients After Treatment With Sofosbuvir and Daclatasvir

International Journal of Current Microbiology and Applied Sciences
2018English

Cost Effectiveness Analysis of Sofosbuvir and Ledipasvir/Sofosbuvir in Hepatitis C Virus (HCV) Patients

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2016English

Risk Factors for Hepatitis C Virus Infection in Canadian Patients With Chronic Type C Hepatitis

Canadian Journal of Gastroenterology
1995English

Sofosbuvir and Ribavirin for Hepatitis C in Patients With HIV Coinfection

JAMA - Journal of the American Medical Association
Medicine
2014English

Hemodialysis Patients Treated for Hepatitis C Using a Sofosbuvir-Based Regimen

Kidney International Reports
Nephrology
2017English

The Distribution of Hepatitis C Virus Genotypes in Patients With Chronic Hepatitis C Infection

Türk Mikrobiyoloji Cemiyeti Dergisi
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy